Microbix Biosystems Inc. (MBXBF)

Market Cap	24.85M
Revenue (ttm)	15.50M
Net Income (ttm)	-238.17K
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,650
Average Volume	62,115
Open	0.1767
Previous Close	0.1785
Day's Range	0.1767 - 0.1804
52-Week Range	0.1727 - 0.3871
Beta	0.24
RSI	15.21
Earnings Date	Aug 11, 2025

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. I...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 100
• Stock Exchange: OTCMKTS
• Ticker Symbol: MBXBF

Financial Performance

Financial numbers in CAD